We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Industry Insights

A Conversation With Professor Josef Penninger on the Journey to a COVID-19 Therapeutic
Industry Insight

The ACE2 receptor has garnered significant attention for the wrong reasons over recent months. Could it point towards an exit route out of this pandemic? In an interview with Technology Networks, the renowned immunologist Professor Josef Penninger explains why he thinks so, and discusses the latest clinical data obtained from testing the soluble ACE2 receptor, APN01.

Read More

How Can Healthcare Workers Keep Up With the Latest Research?
Industry Insight

Between caring for patients and battling global pandemics, healthcare workers have a lot on their plate. How can healthcare workers make time to keep abreast of the latest literature in their field?

Read More

LAMP-Based Testing for COVID-19
Industry Insight

Technology Networks recently spoke to Dr Gary Keating, Chief Technical Officer at Hibergene Diagnostics, to learn more about LAMP technology and the advantages it could offer for COVID-19 testing. Gary also discussed some of the challenges faced when developing diagnostics and how the COVID-19 pandemic has impacted diagnostic design and manufacturing.

Read More

COVID-19 Antibody Testing: S vs. N Protein
Industry Insight

Technology Networks spoke to Dr Iswariya Venkataraman, Scientific Affairs Lead at EUROIMMUN US, to learn about the differences between the S and N proteins and what makes them suitable as target antigens in serology testing. Iswariya also discussed the findings and implications from a study which cautioned against the extensive use of tests that detect antibodies against the N protein only.

Read More

From Vaccine Printers to DNA Data Storage, What's in Store for the Future of Synthetic Biology?
Industry Insight

Scientists are harnessing the power of synthetic biology – a field of science that involves redesigning biological components to generate novel synthetic entities – to solve scientific problems and drive innovation in medicine. Technology Networks recently spoke with Codex DNA’s CEO Todd R. Nelson to learn about the impact synthetic biology techniques are having on pharmaceutical development and the "big trends" in synthetic biology we are already seeing and are expected to see in the next few years.

Read More

Using Organoids in the Study of Infectious Diseases
Industry Insight

By providing greater physiologic relevance and a species- or patient-specific test platform, organoids overcome many limitations of conventional 2D cultures and even live-animal disease models.

Read More

Exploring SARS-CoV-2 Antibody Testing
Industry Insight

Technology Networks spoke to Jeff Hawkins, Dr Jerry Yeo, and Dr Abhijit Datta, to learn how the information provided by antibody tests can be used appropriately during the COVID-19 pandemic.

Read More

Which COVID-19 Vaccines Are in Human Clinical Trials?
Industry Insight

A hub page dedicated to bringing you the latest updates on which COVID-19 vaccines are in human clinical trials.

Read More

Tapping Into Information Locked in Our T Cells To Fight COVID-19
Industry Insight

T cells are an important part of our immune memory and offer a wealth of valuable information about the way our bodies perceive and respond to pathogens. Learn how this information is being harnessed and applied in the fight against COVID-19.

Read More

Why Automation Will be the Cornerstone of the Post-COVID Biology Lab
Industry Insight

The 21st century has seen a revolution in how we approach research. With the advent of new technologies like automation and machine/deep learning, biology is becoming a less inferential and more data-driven discipline. With scientific research delayed worldwide due to the COVID-19 pandemic, is it time to re-examine the future role of automation in biological research?

Read More

 
Advertisement